Smartkarma: ECM Coverage Weekly Update (22 July 2017)
The Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs. This week's listings...
322 Views
JNJ's REMICADE Holds: PFE's Results To Confirm
Johnson & Johnson (JNJ US) reported Q2 2017 results today (quotes from earnings call are below). US revenue for REMICADE (reference product for...
517 Views
Celltrion Healthcare IPO Part 6 - IPO Bookbuilding Results
Celltrion Healthcare (091990 KS) IPO price was set at ₩41,000, which is the highest level of the indicative price band (₩32,500 - ₩41,000). The...
229 Views
Celltrion Healthcare IPO Part 5 - Regulatory Concerns & Possible M&A Options
Korea's Anti-Trust Law now says that any business group (those so-called chaebols or large conglomerates) with combined assets of ₩10tril are...
192 Views
Valuation of Celltrion + Celltrion Healthcare Is Not as Expensive as Samsung Biologics
Celltrion Healthcare (091990 KS) (CH) is raising US$701 - 884m in its upcoming IPO. Proceeds raised will be used to fund general working capital,...
301 Views